Results 171 to 180 of about 377,869 (311)

Changes in Indices of Steatosis and Fibrosis in Liver Grafts of Living Donors After Weight Reduction. [PDF]

Front Surg, 2022
Choi J, Choi Y, Hong SY, Suh S, Hong K, Han ES, Lee JM, Hong SK, Yi NJ, Lee KW, Suh KS.   +10 more
europepmc   +1 more source

LDAcoop: Integrating non‐linear population dynamics into the analysis of clonogenic growth in vitro

Molecular Oncology, EarlyView.
Limiting dilution assays (LDAs) quantify clonogenic growth by seeding serial dilutions of cells and scoring wells for colony formation. The fraction of negative wells is plotted against cells seeded and analyzed using the non‐linear modeling of LDAcoop.
Nikko Brix, Daniel Samaga, Katharina Gehr, Benedek Dankó, Mohamed Schumann, Guido Drexler, Ahmed Alnatsha, Georg Beyer, Ujjwal Mahajan, Martin Selmansberger, Julia Mayerle, Claus Belka, Horst Zitzelsberger, Kirsten Lauber   +13 more
wiley   +1 more source

Strategies for Monitoring and Supporting Living Donors in Korea: An Expert Position Paper. [PDF]

J Korean Med Sci
Kang E, Woo HY, Hong SY, Lee H, Min S, Ha J.   +5 more
europepmc   +1 more source

Impact of having potential living donors on ethnic/racial disparities in access to kidney transplantation. [PDF]

Am J Transplant, 2022
Gordon EJ, Lee J, Kang R, Caicedo JC.
europepmc   +1 more source

Plecstatin inhibits hepatocellular carcinoma tumorigenesis and invasion through cytolinker plectin

Molecular Oncology, EarlyView.
The ruthenium‐based metallodrug plecstatin exerts its anticancer effect in hepatocellular carcinoma (HCC) primarily through selective targeting of plectin. By disrupting plectin‐mediated cytoskeletal organization, plecstatin inhibits anchorage‐dependent growth, cell polarization, and tumor cell dissemination.
Zuzana Outla, Jan Kosla, Magdalena Prechova, Lukas Frick, Patricia Bortel, Yasmin Borutzki, Andrea Bileck, Christopher Gerner, Samuel M. Meier‐Menches, Selma Osmanagic‐Myers, Martin Gregor   +10 more
wiley   +1 more source

Cryopreserved Total Skin Allografts From Living Donors for Complex Wound Management: A New Paradigm in Regenerative Wound Care. [PDF]

Int Wound J
Fonseca M, Cañete A, Mandriaza L, Gómez J, Masiá J, Marcelain K, Ibaceta D, Erazo C, Gámez B, Rius M, Disi F.   +10 more
europepmc   +1 more source

Concerns and Challenges of Living Donors When Making Decisions on Organ Donation: A Qualitative Study. [PDF]

Iran J Nurs Midwifery Res, 2022
Bahador RS, Farokhzadian J, Mangolian P, Nouhi E.   +3 more
europepmc   +1 more source

Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition

Molecular Oncology, EarlyView.
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li, Shuichi Tatarano, Hirofumi Yoshino, Saeki Saito, Mitsuhiko Tominaga, Junya Arima, Ikumi Fukuda, Takashi Sakaguchi, Ryosuke Matsushita, Yasutoshi Yamada, Hideki Enokida   +10 more
wiley   +1 more source

Staged preoperative evaluation of potential living donors for liver transplantation. [PDF]

Transl Gastroenterol Hepatol
Sotomayor C, García D, Rebolledo P, Dominguez MP, Pastoré A, Achurra P, Viñuela E, Arab JP, Benitez C, Huete A, Briceño E, Martinez J, Jarufe N, Dib MJ.   +13 more
europepmc   +1 more source

Testing the Differential Access Hypothesis That Black Kidney Transplant Candidates Perceive Social Network Access to Fewer Potential Living Donors Than White Candidates. [PDF]

Prog Transplant, 2023
Daw J, Roberts M, Gillespie A, Verdery AM, Purnell TS.   +4 more
europepmc   +1 more source